Symbols / LGND Stock $226.87 +0.09% Ligand Pharmaceuticals Incorporated

Healthcare • Biotechnology • United States • NGM
LGND (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Fundamentals
Scroll to Statements
Market Cap 4.52B Enterprise Value 4.24B Income 124.45M Sales 268.09M Book/sh 51.44 Cash/sh 36.78
Dividend Yield — Payout 0.00% Employees 47 IPO — P/E 37.01 Forward P/E 22.84
PEG 1.53 P/S 16.88 P/B 4.41 P/C — EV/EBITDA 52.34 EV/Sales 15.81
Quick Ratio 21.83 Current Ratio 22.23 Debt/Eq 44.39 LT Debt/Eq — EPS (ttm) 6.13 EPS next Y 9.93
EPS Growth — Revenue Growth 39.40% Earnings 2026-05-07 ROA 2.36% ROE 13.47% ROIC —
Gross Margin 64.29% Oper. Margin 33.59% Profit Margin 46.42% Shs Outstand 19.94M Shs Float 19.47M Short Float 9.03%
Short Ratio 6.33 Short Interest — 52W High 238.31 52W Low 98.89 Beta 1.00 Avg Volume 217.57K
Volume 110.05K Target Price $246.70 Recom Strong_buy Prev Close $226.67 Price $226.87 Change 0.09%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$78.61
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest LGND news

No recent news from Yahoo. Try the RSS feed for latest LGND news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-01 KOZARICH JOHN W. Director — 467 $199.97 $94,440
2026-04-01 REARDON ANDREW THOMAS Officer — 5,000 $198.85 $1,006,224
2026-04-01 REARDON ANDREW THOMAS Officer — 5,000 $52.27 $261,350
2026-03-23 SABBA STEPHEN L. Director — 1,000 $207.87 $207,873
2026-03-11 ESPINOZA OCTAVIO Chief Financial Officer — 3,057 $225.00 $687,825
2026-03-11 ESPINOZA OCTAVIO Chief Financial Officer — 2,405 $92.65 $222,823
2026-03-06 LAMATTINA JOHN L Director — 2,161 $200.76 $433,842
2026-03-06 LAMATTINA JOHN L Director — 2,161 $114.15 $246,678
2026-03-04 ESPINOZA OCTAVIO Chief Financial Officer — 13,423 $198.71 $2,762,822
2026-03-04 ESPINOZA OCTAVIO Chief Financial Officer — 2,073 $58.49 $131,609
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category